Circadian rhythm: from preclinical to post-diagnosis dementia

The RHYTHM IN DEMENTIA project aims to identify circadian rhythm features linked to dementia risk and progression, using accelerometry and biomarkers to inform prevention strategies.

Subsidie
€ 1.999.982
2023

Projectdetails

Introduction

Circadian rhythm (CR) regulates body functions over the 24-hour day/night period; the sleep/wake cycle is its most visible manifestation. CR disruptions have long been observed in patients with dementia, and emerging evidence points to their presence in the preclinical period of dementia.

Significance of CR in Dementia

This suggests that certain aspects of CR could be useful in the identification of high-risk individuals and could serve as potential targets for interventions to delay dementia onset and progression. This requires an in-depth understanding of the role of CR in dementia pathogenesis.

Need for Strategies

As population ageing increases dementia burden, it is critical to find strategies to identify patients at risk of dementia with precision, prevent, and slow its progression.

Project Overview

Building on recent advances in accelerometry (to assess CR features comprehensively) and dementia biomarkers (deep-phenotyping of dementia pathogenesis), RHYTHM IN DEMENTIA will make a decisive step-change in knowledge by determining CR features involved in dementia processes along the course of the disease.

Aims of the Project

The aims are:

  1. Identify core CR features that shape 10-year risk of dementia in a community-dwelling cohort of 4000 older adults.
  2. Uncover specific CR disruptions that characterize major dementia subtypes and stages of Alzheimer’s disease (determined by biomarkers) in a new cohort of 1500 patients recruited from two memory clinics in Paris.
  3. Ascertain how CR affects dementia prognosis in the patient cohort by examining cognitive and functional decline, hospitalization, institutionalization, and mortality.

Expected Outcomes

This project will yield new insight into the nature of the association between CR and dementia progression. These findings will ultimately inform the potential for a cost-effective and easy-to-use tool to assess CR features to facilitate both the identification of patients at risk of dementia and tailored secondary prevention interventions that address CR disruptions in dementia patients and slow the progression of dementia.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.999.982
Totale projectbegroting€ 1.999.982

Tijdlijn

Startdatum1-5-2023
Einddatum30-4-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALEpenvoerder
  • ASSISTANCE PUBLIQUE HOPITAUX DE PARIS

Land(en)

France

Vergelijkbare projecten binnen European Research Council

ERC Advanced...

Targeting the circadian clock in personalized disease prevention

This project aims to identify and mitigate health risks associated with disrupted circadian rhythms in night workers through genetic profiling and targeted interventions for healthier aging.

€ 2.499.965
ERC Proof of...

Pre-commercialization of circadian clock-drug interactions screening tool for therapeutic applications

The CIRCOMMUNICATION project aims to commercialize CircaSCOPE, a high-throughput method for constructing Phase Transition Curves to enhance drug efficacy and minimize side effects through chronotherapy.

€ 150.000
ERC Starting...

Map and manipulate sleep oscillations to reveal their role in healthy cognitive development

This project aims to investigate the causal relationship between sleep architecture and cognitive development in young mammals using advanced neurobiological techniques to inform therapeutic strategies for developmental disorders.

€ 1.500.000
ERC Advanced...

The Silent Phase of Alzheimer’s Disease: From Brain States to Homeostatic Failures

This project aims to uncover the mechanisms stabilizing hippocampal circuits and their relation to Alzheimer's disease by exploring homeostatic regulation across brain states using diverse experimental tools.

€ 2.500.000
ERC Consolid...

The early ticking of the central circadian pacemaker: when and how

StarTicking aims to uncover the development and functionality of the circadian clock in mice and humans, linking early environmental factors to behavioral outcomes in pre-term infants.

€ 1.955.875

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

EEGX2

Dit project ontwikkelt een softwaretool voor vroegtijdige dementiedetectie via EEG-analyse, gebruikmakend van goedkope hardware en geavanceerde algoritmes, in samenwerking met zorginstellingen.

€ 120.943
EIC Pathfinder

twiN-on-a-chip brAins for monitoring individual sleeP habits

NAP aims to revolutionize sleep research by developing personalized in vitro models to identify sleep disorders and early Parkinson's Disease signs, enhancing diagnostics and reducing healthcare costs.

€ 3.615.375
Mkb-innovati...

Haalbaarheid op data gebaseerde gepersonaliseerd leefstijladvies t.b.v. cognitieve gezondheid

Tolooba B.V. ontwikkelt een verbeterde Memory Up-applicatie die cognitieve training en gepersonaliseerd leefstijladvies combineert om geheugenverlies te bestrijden en de cognitieve gezondheid te bevorderen.

€ 20.000